Evidence map›Paper›PMID 32868830›Full record

ArticleScientific reports2020

Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells.

Taito Miyake, Norihiko Sakai, Akira Tamai, Koichi Sato, Yasutaka Kamikawa, Taro Miyagawa, Hisayuki Ogura, Yuta Yamamura, Megumi Oshima, Shiori Nakagawa and 10 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Autophagy in peritoneal fibrosis.Frontiers in physiology · 2023
    Review
  5. Review
  6. Article
  7. DOCK2 Promotes Pleural Fibrosis by Modulating Mesothelial to Mesenchymal Transition.American journal of respiratory cell and molecular biology · 2022
    Article
  8. Blueberry Juice Attenuates Pulmonary FibrosisFrontiers in pharmacology · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Taito MiyakeDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.ORCID http://orcid.org/0000-0002-2416-2181
Norihiko SakaiDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan. norin0826@staff.kanazawa-u.ac.jp.
Akira TamaiDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Koichi SatoDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Yasutaka KamikawaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Taro MiyagawaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Hisayuki OguraDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Yuta YamamuraDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Megumi OshimaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Shiori NakagawaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Akihiro SagaraDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Yasuyuki ShinozakiDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Tadashi ToyamaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Shinji KitajimaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Akinori HaraDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Yasunori IwataDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Miho ShimizuDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Kengo FuruichiDivision of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Ishikawa, 920-0293, Japan.
Shuichi KanekoDepartment of System Biology, Institute of Medical, Pharmaceutical and Health Science, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.
Takashi WadaDivision of Nephrology, Kanazawa University Hospital, Kanazawa, 920-8641, Japan. twada@m-kanazawa.jp.
Kanazawa University Hospital · JPKanazawa University · JPKanazawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal fibrosis (PF) is a severe complication of peritoneal dialysis, but there are few effective therapies for it. Recent studies have revealed a new biological function of trehalose as an autophagy inducer. Thus far, there are few reports regarding the therapeutic effects of trehalose on fibrotic diseases. Therefore, we examined whether trehalose has anti-fibrotic effects on PF. PF was induced by intraperitoneal injection of chlorhexidine gluconate (CG). CG challenges induced the increase of peritoneal thickness, ColIα

Indexed as

AnimalsChlorhexidineEpithelial CellsEpithelial-Mesenchymal TransitionMaleMiceMice, Inbred C57BLMyofibroblastsPeritoneal FibrosisSnail Family Transcription FactorsTrehaloseChlorhexidinechlorhexidine gluconateSnai1 protein, mouseSnail Family Transcription FactorsTrehalose

Identifiers

PMID32868830
PMCPMC7459354
OpenAlexW3082188785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.